OGF-OGFr axis can be modulated in human triple-negative breast cancer cells to inhibi

[News]

Researchers at The Pennsylvania State University College of Medicine, led by Dr. Ian S. Zagon, have discovered that a novel biological pathway, the OGF-OGFr axis, can be modulated in human triple-negative breast cancer cells to inhibit proliferation. According to BreastCancer.org 1 in 8 women in the U.S. will develop invasive breast cancer and more than 39,000 deaths occur annually.

More... (http://www.news-medical.net/news/20130812/OGF-OGFr-axis-can-be-modulated-in-human-triple-negative-breast-cancer-cells-to-inhibit-proliferation.aspx)